Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Nature is not a place to visit . It is home . - Gary Snyder . The humble apple, a staple fruit in many cultures, harbors a ...